相关实验视频

Updated: Jun 5, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K

在多发性骨髓瘤的诱导治疗期间,更高的症状负担的轨迹,相互作用和预测因素

Mona Kamal1, Qiuling Shi2, Shu-En Shen1

  • 1Department of Symptom Research, Unit 1450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

Journal of patient-reported outcomes
|December 4, 2024
PubMed
概括

近三分之一的多发性骨髓瘤患者在治疗期间经历了持续的,严重的症状,如疼痛和疲劳. 早期干预和监测这些症状对于改善患者的治疗结果和生活质量至关重要.

关键词:
诱导疗法是一种诱导疗法.多发性骨髓瘤是一种多发性骨髓瘤.患者报告的结果 (PROs)症状负担是因为症状负担.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.3K
Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.2K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K